Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1997 Apr;6(2):135–139. doi: 10.1080/09629359791839

Cytokine changes in patients with heatstroke during pilgrimage to Makkah

I A Hashim 1,✉, A Al-Zeer 4, S Al-Shohaib 2, M Al-Ahwal 3, A Shenkin 5
PMCID: PMC2365856  PMID: 18472847

Abstract

Circulating levels and role of IL-6, IL-1ra, TNFsr-II and CRP in patients with heatstroke is not fully known. This study correlated levels of these mediators with outcome in 26 patients. In survivors (n=20), IL-6 concentration declined on cooling, whereas in non-survivors levels continued to increase at 6 h following admission before declining. Admission TNFsr-II concentrations in survivors were significantly lower than non-survivors and levels continued to rise in both groups. IL-1ra levels were markedly elevated in both groups. Changes in cytokine levels were not influenced by renal function. Elevated C-reactive protein levels were observed for both groups and remained so despite cooling, furthermore, there was no correlation with alanine aminotransferase levels. The study demonstrated the elevation of the above mediators and suggested a role in the pathogenesis of heatstroke. Markedly elevated levels or those that remained elevated despite cooling were associated with mortality.

Full Text

The Full Text of this article is available as a PDF (175.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andus T., Gross V., Holstege A., Ott M., Weber M., David M., Gallati H., Gerok W., Schölmerich J. High concentrations of soluble tumor necrosis factor receptors in ascites. Hepatology. 1992 Sep;16(3):749–755. doi: 10.1002/hep.1840160322. [DOI] [PubMed] [Google Scholar]
  2. Arend W. P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest. 1991 Nov;88(5):1445–1451. doi: 10.1172/JCI115453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bouchama A., Parhar R. S., el-Yazigi A., Sheth K., al-Sedairy S. Endotoxemia and release of tumor necrosis factor and interleukin 1 alpha in acute heatstroke. J Appl Physiol (1985) 1991 Jun;70(6):2640–2644. doi: 10.1152/jappl.1991.70.6.2640. [DOI] [PubMed] [Google Scholar]
  4. Chang D. M. The role of cytokines in heat stroke. Immunol Invest. 1993 Dec;22(8):553–561. doi: 10.3109/08820139309084183. [DOI] [PubMed] [Google Scholar]
  5. Chouaib S., Branellec D., Buurman W. A. More insights into the complex physiology of TNF. Immunol Today. 1991 May;12(5):141–142. doi: 10.1016/S0167-5699(05)80041-6. [DOI] [PubMed] [Google Scholar]
  6. Clowes G. H., Jr, O'Donnell T. F., Jr Heat stroke. N Engl J Med. 1974 Sep 12;291(11):564–567. doi: 10.1056/NEJM197409122911106. [DOI] [PubMed] [Google Scholar]
  7. Fischer E., Marano M. A., Van Zee K. J., Rock C. S., Hawes A. S., Thompson W. A., DeForge L., Kenney J. S., Remick D. G., Bloedow D. C. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest. 1992 May;89(5):1551–1557. doi: 10.1172/JCI115748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
  9. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb 1;265(3):621–636. doi: 10.1042/bj2650621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990 Feb 1;265(3):621–636. doi: 10.1042/bj2650621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Keatinge W. R., Coleshaw S. R., Easton J. C., Cotter F., Mattock M. B., Chelliah R. Increased platelet and red cell counts, blood viscosity, and plasma cholesterol levels during heat stress, and mortality from coronary and cerebral thrombosis. Am J Med. 1986 Nov;81(5):795–800. doi: 10.1016/0002-9343(86)90348-7. [DOI] [PubMed] [Google Scholar]
  12. Knochel J. P. Heat stroke and related heat stress disorders. Dis Mon. 1989 May;35(5):301–377. [PubMed] [Google Scholar]
  13. Seckinger P., Isaaz S., Dayer J. M. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem. 1989 Jul 15;264(20):11966–11973. [PubMed] [Google Scholar]
  14. Van Zee K. J., Kohno T., Fischer E., Rock C. S., Moldawer L. L., Lowry S. F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4845–4849. doi: 10.1073/pnas.89.11.4845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wildeboor J., Camp J. Heat stress: its effect and control. AAOHN J. 1993 Jun;41(6):268–274. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES